English  |  正體中文  |  简体中文  |  總筆數 :2822924  
造訪人次 :  30013054    線上人數 :  1060
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"zeng l"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-10 / 23 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-06-27T06:59:40Z Osimertinib in resected EGFR-mutated non–small-cell lung cancer Wu Y.-L.; Tsuboi M.; He J.; John T.; Grohe C.; Majem M.; Goldman J.W.; Laktionov K.; Kim S.-W.; Kato T.; Vu H.-V.; Lu S.; Lee K.-Y.; Akewanlop C.; CHONG-JEN YU; de Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Zeng L.; Hodge R.; Atasoy A.; Rukazenkov Y.; Herbst R.S.
臺大學術典藏 2022-06-27T06:59:32Z A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer Wu Y.-L.; Tsuboi M.; John T.; Grohe C.; Majem M.; Goldman J.W.; Laktionov K.; Kim S.-W.; Kato T.; Vu H.-V.; Lu S.; Lee K.-Y.; Akewanlop C.; CHONG-JEN YU; De Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Zeng L.; Hodge R.; Atasoy A.; Rukazenkov Y.; Herbst R.S.
臺大學術典藏 2022-06-27T06:59:30Z Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC Wu Y.-L.; John T.; Grohe C.; Majem M.; Goldman J.W.; Kim S.-W.; Kato T.; Laktionov K.; Vu H.V.; Wang Z.; Lu S.; Lee K.Y.; Akewanlop C.; CHONG-JEN YU; de Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Zeng L.; Atasoy A.; Herbst R.S.; Tsuboi M.
臺大學術典藏 2022-06-27T06:59:29Z Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial Majem M.; Goldman J.W.; John T.; Grohe C.; Laktionov K.; Kim S.-W.; Kato T.; Vu H.V.; Lu S.; Li S.; Lee K.Y.; Akewanlop C.; CHONG-JEN YU; de Marinis F.; Bonanno L.; Domine M.; Shepherd F.A.; Atagi S.; Zeng L.; Kulkarni D.; Medic N.; Tsuboi M.; Herbst R.S.; Wu Y.-L.
臺大學術典藏 2022-05-05T09:10:20Z Quality of life after palliative radiation therapy for patients with painful bone metastases: Results of an international study validating the EORTC QLQ-BM22 Zeng L.; Chow E.; Bedard G.; Zhang L.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE; Bottomley A.
臺大學術典藏 2022-05-05T09:10:19Z Comparison of baseline quality of life scores in patients with bone and brain metastases as assessed using the EORTC QLQ-C15-PAL Di Giovanni J.; Zeng L.; Zhang L.; Vassiliou V.; Satoh T.; Foro P.; Ma B.B.Y.; WEI-CHU CHIE; Sahgal A.; Poon M.; Chow E.
臺大學術典藏 2022-05-05T09:10:19Z An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases Zeng L.; Chow E.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Forges F.; WEI-CHU CHIE; Bedard G.; Bottomley A.
臺大學術典藏 2022-05-05T09:10:18Z Comparison of baseline quality of life scores in patients with bone and brain metastases as assessed using the EORTC QLQ-C30 Poon M.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE; Sahgal A.; Wong E.; Chow E.
臺大學術典藏 2022-05-05T09:10:16Z Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30 Lam K.; Zeng L.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Pharmd F.F.; WEI-CHU CHIE; Sahgal A.; Poon M.; Chow E.
臺大學術典藏 2022-05-05T09:10:16Z Predictive factors for overall quality of life in patients with advanced cancer Cramarossa G.; Chow E.; Zhang L.; Bedard G.; Zeng L.; Sahgal A.; Vassiliou V.; Satoh T.; Foro P.; Ma B.B.Y.; WEI-CHU CHIE; Chen E.; Lam H.; Bottomley A.

顯示項目 1-10 / 23 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目